-+ 0.00%
-+ 0.00%
-+ 0.00%

Cube Pharmaceutical announced that the company signed the “MAH Transfer Contract for Mesalazine Enteric Tablets” with Sunflower Pharmaceutical Group Jiamusi Luling Pharmaceutical Co., Ltd. and decided to transfer ownership of mesalazine enteric tablets for 34 million yuan.

Zhitongcaijing·12/30/2025 11:41:07
Listen to the news
Cube Pharmaceutical announced that the company signed the “MAH Transfer Contract for Mesalazine Enteric Tablets” with Sunflower Pharmaceutical Group Jiamusi Luling Pharmaceutical Co., Ltd. and decided to transfer ownership of mesalazine enteric tablets for 34 million yuan.